Beth Israel Lahey Health Pharmacy Inc.

“For the period covered by this filing, beth israel lahey health, inc. Served as the sole member of beth israel deaconess medical center, inc. (bidmc), mount auburn hospital (mah), new england baptist hospital (nebh), beth israel deaconess hospital milton, inc. (milton), beth israel deaconess hospital needham, inc. (needham), beth israel deaconess hospital plymouth, inc. (plymouth), lahey health shared services, lahey clinic foundation, winchester hospital (winchester), northeast hospital corporation (nhc), northeast behavioral health corporation (nbhc) and anna jaques hospital). Each of these affiliates may have, in turn, served as member of additional entities within the bilh network of affiliates. In addition, harvard medical faculty physicians at beth israel deaconess medical center, inc. (hmfp) is the dedicated physician practice of bidmc and an entity integrally related to helping bidmc and other affiliates in the bilh network accomplish their charitable purposes. For this same period hmfp served as the sole member of affiliated physicians of harvard medical faculty physicians at beth israel deaconess medical center (aphmfp) as well as several additional entities. Two or more of the persons listed in this form 990 part vii have a business relationship with each other by virtue of sitting on one or more boards of directors/trustees or by serving in an employment relationship with one or more entities within the network of the affiliated organizations noted above. Additional detail is provided in the explanatory notes to this form 990 schedule j.”

“For the period covered by this filing, beth israel deaconess medical center, inc. (bidmc) served as the sole member of bidmc pharmacy (pharmacy). According to the pharmacy's bylaws in effect for this period, bidmc had the following rights: - to determine the number of members of the corporation's board of directors; - to appoint all members of the board of directors at the member's sole discretion and to be elected at the annual meeting of the member; in addition, any vacancy in the board may be filled by the president, subject to prior consultation with and the approval of the member. The member also has such powers and authority as are conferred by law, or the articles of organization of the corporation (as amended from time to time), or these bylaws.”

“The member has the authority to elect the governing body.”

“The member of bidmc pharmacy, inc. Has the following rights, as designated in bidmc pharmacy, inc.'s bylaws: the member has such powers and authority as are conferred by law, or the articles of organization of the corporation (as amended from time to time), or these bylaws.”

“As noted in various disclosures throughout this filing, beth israel lahey health, inc. (bilh) is the sole member of beth israel lahey health pharmacy f/k/a bidmc pharmacy, inc.. This form 990 is prepared in conjunction with the beth israel lahey health pharmacy f/k/a bidmc pharmacy, inc. Finance staff. In addition, the bilh tax department works with other disciplines and departments within bilh, beth israel lahey health pharmacy f/k/a bidmc pharmacy, inc. And other affiliates to ensure that other financial and non-financial disclosures are complete and accurate. Examples of such departments may include: financial assistance and reimbursement, compliance, graduate medical education, legal, community benefits, governance, development, human resources and payroll, government relations, research and/or research finance. The tax returns reviewed by the bilh executive director, taxation, beth israel lahey health pharmacy f/k/a bidmc pharmacy, inc.'s chief financial officer and deloitte tax, llp. A copy of the complete return is then provided to each member of beth israel lahey health pharmacy f/k/a bidmc pharmacy, inc.'s board of trustees prior to submission to the internal revenue service.”

“Bidmc pharmacy is a member of the beth israel lahey health (bilh) system of affiliates. All entities in the bilh network adhere to the bilh conflict of interest policy and maintain a written, comprehensive conflict of interest policy at the entity level. Pursuant to these policies, all of [first-tier entity]'s officers, trustees and key employees are required to complete the annual conflict of interest and tax questionnaire which is designed to require disclosure of any business relationships and affiliations maintained by officers, trustees, or key employees and their family members and which may result in a real or perceived conflict of interest. The bilh office of integrity and compliance, in conjunction with the bilh tax department, administers the conflict of interest and tax questionnaire process annually. Bilh integrity and compliance collects and reviews all disclosures. Disclosures for bilh executives and key employees are assigned appropriate follow-up action in accordance with the bilh policy. A summary of positive responses of [first-tier entity] is provided to the [first-tier entity]'s compliance officer for review final determination of any potential or actual conflict. Any activity that requires action under the conflict of interest policies is subject to ongoing review by [first-tier entity] as well as the bilh integrity and compliance office. Pursuant to the bilh conflict of interest policy, certain activities which could create conflicts of interest are prohibited while other types of relationships are permitted, subject to compliance with a management plan to require disclosure and recusal, including appropriate documentation in the minutes. In addition as noted above, the annual conflict of interest process outline above is jointly issued by the bilh tax department, to ensure that the questionnaire is distributed to all current and former members of the [first-tier entity] board of trustees as well as former officers and key employees. The tax questionnaire process is designed to gather the information necessary for [first-tier entity] to completely and accurately complete form 990 schedule l, transactions with interested persons and form 990, part vi, question 2, family and business relationships between officers, directors/trustees and key employees.”

“For the period covered by this filing, the bidmc pharmacy president also served as the chief executive officer of the medical center. The medical center has a compensation committee that is composed of members of its board of directors. All members are independent. For the period covered by this filing, the compensation committee established the policies and the compensation structure of the bidmc chief executive officer, president, chief financial officer, clinical chiefs of service, chief academic officer, chief information officer, general counsel, sr. Vice presidents, vice presidents. The compensation committee was responsible for assuring that the total compensation provided to these individuals was fair and reasonable using current and credible market practice information and that it complied with applicable legal and regulatory guidelines. In setting compensation, the compensation committee relied upon written compensation surveys and studies produced by an independent compensation consulting firm that regularly assesses executive compensation and benefits of similar organizations. The compensation committee met to review the compensation structure of the individuals described above and at that time reviewed the compensation survey prepared by the independent compensation consulting firm. To ensure independence, the chief human resources officer recused herself from discussions and voting related to her own compensation packages and from discussions related to the president and ceo's compensation package. The compensation committee then voted to approve the compensation arrangements of all individuals described above except for the ceo. The compensation package for the ceo voted by the compensation committee was submitted to the full board of directors for approval. All deliberations were contemporaneously documented in minutes. Subsequent to the vote of the committee, the outside consulting firm provided a "reasonableness letter" attesting to the independence of the committee and reasonableness of the executive compensation.”

“Bidmc pharmacy, inc.'s governing documents, conflict of interest policy and financial statements are available to the general public upon request at the following location: beth israel lahey health tax department 109 brookline avenue, suite 300 boston, ma 02215”

“Conflict of interest policy and explanation of monitoring and enforcement of conflicts as previously noted, bidmc is the sole member of the bidmc pharmacy. The pharmacy's operations are integrally related to bidmc. As noted here and in this form 990 schedule j, for the period covered by this filing, the pharmacy's president also served as the bidmc chief executive officer, the pharmacy's treasurer also served as the assistant treasurer of bidmc and the pharmacy's secretary served as bidmc 's general counsel. Although the pharmacy had not formally adopted a conflict of interest policy, based on the pharmacy's close and integral connection to bidmc, the pharmacy followed the medical center's conflict of interest policy and the medical center's procedures for monitoring conflicts. For the period covered by this filing, the medical center maintained a written, comprehensive conflict of interest policy that applied to all members of its workforce, including employees, professional staff, trainees, consultants, contractors, agents, and vendors, and to the members of the board of directors. In addition, harvard medical faculty physicians at beth israel deaconess medical center (hmfp) is an integrally related entity to the medical center and employs the majority of physicians providing patient care at the medical center. Hmfp also has a comprehensive conflict of interest policy. Pursuant to these policies, all members of the medical center's workforce, including the workforce of the pharmacy and employees who serve on the pharmacy board, must disclose conflicts of interest at the time of institutional transactions and must recuse himself/herself from the decision-making regarding the transaction between the medical center, the pharmacy and the outside business in which s/he or a family member has a position or a financial interest. Limited participation in the discussion and/or recommendations about a transaction may be allowed, provided that the person with authority of the final decision-making determines that the involvement is appropriate, and the others involved in the discussion are aware of the financial interest of the conflicted party. The medical center monitors compliance with this policy by requiring all members of the workforce participating in the process to complete a written disclosure form at the time of discussions and negotiations with a supplier and by requiring the supplier to identify in writing those participants who have an outside relationship with the supplier. A supplier's failure to make a required disclosure may result in disqualification from being a supplier and can be grounds for termination of the contract. Similarly, any member of the board of directors of the pharmacy who is in a position to vote on or influence a particular transaction or decision of the pharmacy must notify the pharmacy board if s/he or a family member might materially benefit and recuse himself/herself from participation and voting on the decision. In addition, all officers, directors and key employees of the pharmacy, the medical center and hmfp are required to complete an annual conflict disclosure which is designed to require disclosure of any business relationships maintained by officers, directors or key employees and their immediate family members which may result in a conflict of interest. Pursuant to the medical center's conflict of interest policy, many individuals in addition to those reported on the tax returns are required to complete an annual conflict disclosure. These additional categories include officers, senior management, chiefs of service, division chiefs, and other workforce and professional staff categories as identified from time to time by the chief executive officer, the senior vice president for compliance, audit, and risk or the conflicts of interest committee. For these employees, providing a disclosure is a condition of employment and/or medical staff appointment. In addition, all officers, directors a”

“To maintain and operate one or more pharmacies and engage in any and all activities related or incidental thereto, in support of and for the benefit of beth israel deaconess medical center and its affiliates.”

“The bidmc pharmacy's (pharmacy) purpose is to support patients of its sole member, beth israel deaconess medical center ("bidmc or "medical center"). The medical center is a world-class tertiary care academic medical center and teaching hospital of harvard medical school located in boston and is a hospital exempt from income tax under section 501(c)(3) of the internal revenue code of 1986, as amended. The pharmacy accomplishes its purpose by providing patients of bidmc with access to medication regardless of their ability to pay. On march 1, 2019, the beth israel deaconess system including beth israel deaconess medical center, beth israel deaconess milton, beth israel deaconess needham, and beth israel deaconess plymouth, mount auburn hospital, new england baptist hospital, lahey health system including the lahey clinic and lahey clinic hospital d/b/a lahey hospital and medical center, winchester hospital, northeast hospital corporation d/b/a beverly hospital, addison gilbert hospital and bayridge hospital, anna jaques hospital as well as entities for which these listed organizations serve as sole member and additional affiliates came together to form beth israel lahey health, inc (bilh). Bilh is an integrated health care system committed to expanding access to extraordinary patient care across eastern massachusetts and advancing the science and practice of medicine through groundbreaking research and education. The bilh system is comprised of academic and teaching hospitals, a premier orthopedics hospital, primary care and specialty care providers, ambulatory surgery centers, urgent care centers, community hospitals, homecare services, outpatient behavioral health centers and addiction treatment programs. Bilh's community of clinicians, caregivers and staff includes approximately 4,000 physicians and 35,000 employees.”

“Beth israel lahey health ("bilh") quickly and effectively marshalled its resources to mount a comprehensive response to the covid-19 pandemic. Since the start of the pandemic (through june of 2021), bilh has treated over 8,500 hospitalized patients with covid-19 and performed more than 700,000 covid-19 diagnostic tests. Highlights of the system's pandemic response in fy 2020 include: bilh quickly established an emergency operations center ("eoc") to align system efforts across its hospitals and other business units and with external entities, including the state government. The eoc held regular meetings with incident commanders, emergency managers, and senior leaders from bilh hospitals, primary care, and other system entities to coordinate plans, policies, and communications. It participated in weekly conference of boston teaching hospitals ("cobth") calls and massachusetts department of public health command center calls. A key role of the eoc involved managing the flow of internal and external information to ensure situational awareness and alignment of responses to the pandemic. Finally, the eoc worked with internal and external partners to centralize covid-19 related data collection and reporting for the system, commonwealth, and federal government. In march 2020, beth israel deaconess medical center ("bidmc") became one of the first hospital laboratories in the state to begin in-house high-throughput polymerase chain reaction ("pcr") covid-19 testing for patients and healthcare workers. Bidmc's laboratory provided this test to bilh hospitals and other community partners, such as health centers and corrections facilities, at a time of critical supply shortage. Throughout the pandemic, bilh worked toward additional in-house testing capabilities, including high-throughput thermo fisher instruments at lahey hospital & medical center ("lhmc"). The system operationalized multiple drive-through covid-19 testing sites to enable easy access for patients and staff. In the summer of 2020, to expand hospital and clinic-based covid-19 testing sites, bilh opened an additional high-capacity drive-through testing site in woburn. To ensure continued access to care for its patients, bilh primary care rapidly deployed a telehealth strategy, quickly transitioned to cohort clinics to care for sick patients, and successfully managed a phased reopening by july 2020. Bilh established a temporary community crisis stabilization unit at new england baptist hospital to manage behavioral health patient volume during the pandemic. Bilh established a daily huddle consisting of bilh ed and behavioral health leaders to determine appropriate patient transfers to the unit. Bilh's virtual transfer center was formed in september 2019 to optimize system-wide bed capacity using real-time information exchange among the three existing transfer centers at bidmc, lhmc and mount auburn hospital ("mah"). The transfer team personnel at these centers work together as a single "virtual" center to accommodate incoming transfer requests by making all beds available in the system based on facility capacity and level of care required. The transfer center enhanced patient quality, safety, and access by load balancing covid patients across all of its hospitals so that these patients received timely access to the type of bed and level of care needed. Bilh collaborated with external entities to stand up a 1,000-bed field hospital, the boston hope hospital, and open and staff a covid hotel for underserved communities. Bilh launched a website titled the coronavirus resource center to provide its patient community with up-to-date information regarding the system's response to the pandemic, available resources such as testing sites, and innovation efforts underway throughout bilh (e.g., vaporized hydrogen peroxide sterilization for n95 respirators). Bilh launched an internal website with resources for its staff as well. Bilh created system-wide guidelines for infection prevention”

“Form 990, part iv, line 12 and 12a: the boston, ma office of kpmg issued an unqualified opinion on the consolidated audited financial statements of the beth israel lahey health, inc. And affiliates for fiscal period ended september 30, 2020 these statements were prepared in accordance with generally accepted accounting principles (gaap) and included the accounts of the beth israel lahey health, inc. (bilh), and the entities for which beth israel lahey health, inc. (bilh) served as sole member during the fiscal period covered by this filing, (beth israel deaconess medical center (bidmc), mount auburn hospital (mah), new england baptist hospital (nebh), beth israel deaconess hospital milton, inc. (milton), beth israel deaconess hospital needham, inc. (needham), beth israel deaconess hospital plymouth, inc. (plymouth), lahey clinic foundation, lahey health shared services, winchester hospital (winchester), northeast hospital corporation (nhc), northeast behavioral health corporation (nbhc) and anna jaques hospital). Each of these affiliates may in turn serve as member of additional entities within the network of affiliates, and whose accounts are included in the bilh audited financial statements. The financial statements also include the accounts of harvard medical faculty physicians at beth israel deaconess medical center, inc. (hmfp), the dedicated physician practice of beth israel deaconess medical center and an entity integrally related to helping bidmc and other affiliates in the bilh network accomplish their charitable purposes.”

“Bidmc pharmacy, inc. Did not receive any contributions of intellectual property and as such, was not required to file form 8899.”

“Bidmc pharmacy, inc. Did not receive any contributions of cars, boats, airplanes or other vehicles and as such, was not required to file form 1098-c.”

“As previously reported in this filing, bidmc serves as the sole member of the bidmc pharmacy. Both entities are public charities exempt from income taxes under section 501(c)(3) of the internal revenue code of 1986, as amended. For the period covered by this filing, the financial records of the pharmacy were audited as part of the medical center's consolidated audited financial statement process. For the period covered by this filing, the boston, ma office of kpmg issued an unqualified opinion on these financial statements and the process was monitored and reviewed internally by the medical center's compliance, audit and risk committee.”